OXFORD, England, August 14, 2014 /PRNewswire/ --
The journal will serve as a forum for original research and review articles focusing on the impact of stress on the brain, covering cellular, behavioral functions and stress-related neuropsychiatric disorders such as depression, trauma and anxiety. The translation of basic research findings into real-world applications will be a key aim of the journal.
Stress affects everyone at some point in their lives and is increasingly becoming an issue in today's society. More people are coming under mounting pressures at work, at home and in their social lives.
As a result increasing funding is being made available to conduct research in these areas and therefore the volume of publications dealing with stress is likely to continue to grow in the years to come. We intend that Neurobiology of Stress will help to progress basic research and ultimately develop targeted treatment opportunities for stress-related mental health disorders.
Co-Editor-in-Chief Rita Valentino, Research Professor of Anesthesiology and Critical Care and Director of the Division of Stress Neurobiology at the Children's Hospital of Philadelphia commented: "Recognizing the broad impact of stress on neurobehavioral processes and diseases, research from diverse disciplines has converged on stress neurobiology in recent years. This journal will serve as a forum for timely research and conceptual perspectives in basic and clinical stress neuroscience."
"We are very excited about the launch of the journal. It will provide a home for high quality original research and review papers in this growing field," said Co-Editor-in-Chief, Yvette Sheline, Professor of Psychiatry at the Perelman School of Medicine at the University of Pennsylvania.
Toby Charkin, Executive Publisher for behavioral and cognitive neuroscience journals at Elsevier, added: "I believe Neurobiology of Stress will fill an important niche because of the tremendous growth in stress research in recent years. Clinical awareness of the influence of different types of stress on disease development and recovery is increasing and research being conducted today will have the potential to underpin new treatment paradigms. Also publishing it open access will ensure that the information is freely available for the widest possible audience, which may bring added benefits due to the multidisciplinary nature of research in the field."
For more information or to submit an article, go to: http://www.journals.elsevier.com/neurobiology-of-stress
First articles will be published and available through ScienceDirect by November 2014.
About Open Access Publishing at Elsevier
Elsevier has been providing open access publishing options since 2005. Today, researchers can choose to publish open access in over 1,600 established peer-reviewed journals as well as over 100 full open access journals and these numbers will continue to grow rapidly. All of Elsevier's open access publications have been peer reviewed, ensuring that the broader community not only reads the latest research but that it is factual, original and of the highest quality and ethical standards. For more information about Elsevier's open access program, visit http://www.elsevier.com/openaccess.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey - and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).